Name: UMIN ID:
Unique ID issued by UMIN | UMIN000034081 |
---|---|
Receipt number | R000038854 |
Scientific Title | An investigator-initiated phase I/IIa trial of subretinal injection of DVC1-0401 as neuroprotective gene therapy for retinitis pigmentosa |
Date of disclosure of the study information | 2018/11/01 |
Last modified on | 2022/09/06 10:22:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/09/10 17:41:00 | ||
2 | Update | 2019/02/14 15:59:03 | Recruitment status Anticipated trial start date |
|
3 | Update | 2019/10/01 09:49:45 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Organization Organization Address Address Tel |
|
4 | Update | 2019/10/03 08:43:23 | UMIN ID1 |
|
5 | Update | 2020/06/17 15:12:23 | Co-sponsor Co-sponsor Institutions |
|
6 | Update | 2022/09/05 18:48:29 | Recruitment status Date of IRB Last follow-up date |
|
7 | Update | 2022/09/05 20:15:39 | Number of participants that the trial has enrolled |
|
8 | Update | 2022/09/06 10:22:08 | Date of IRB |